| 期 |
栏目 |
标题 |
文件 |
| 卷 17, 编号 2 (2020) |
Reviews |
Promising compounds from natural sources against COVID-19 |
(Rus)
(Eng)
|
| 卷 17, 编号 3 (2020) |
Original studies |
Molecular allergodiagnostics capabilities in determining the indications for allergen-specific immunotherapy with house dust mites allergen and its effectiveness in atopic dermatitis patients |
(Rus)
(Eng)
|
| 卷 18, 编号 3 (2021) |
Clinical practice guidelines |
Atopic dermatitis |
(Rus)
|
| 卷 18, 编号 3 (2021) |
Clinical practice guidelines |
Vaccination of patients with allergic disease against novel coronavirus infection: position paper of the Russian Association of Allergology and Clinical Immunology |
(Rus)
|
| 卷 18, 编号 3 (2021) |
Clinical practice guidelines |
Vaccination against COVID-19 for patients with primary immunodeficiency and hereditary angioedema: the position paper of the Russian Association of Allergology, Clinical Immunology, and the National Association of Experts in Primary Immunodeficiencies |
(Rus)
|
| 卷 19, 编号 1 (2022) |
Clinical practice guidelines |
Allergic rhinitis |
(Rus)
|
| 卷 19, 编号 3 (2022) |
Original studies |
Study of the silver birchpollen allergoid |
|
| 卷 20, 编号 4 (2023) |
Original studies |
Cationic peptides as promising compounds for the treatment of bacterial complications in atopic dermatitis: Antibacterial activity assessment |
|
| 卷 20, 编号 4 (2023) |
Reviews |
Diagnostic and prognostic value of biomarkers in atopic dermatitis for assessing its endotypes, phenotypes, and treatment efficacy |
(Rus)
|
